144 related articles for article (PubMed ID: 38271295)
1. Use of isotretinoin among girls and women of childbearing age and occurrence of isotretinoin-exposed pregnancies in Germany: A population-based study.
Reinold J; Kollhorst B; Wentzell N; Platzbecker K; Haug U
PLoS Med; 2024 Jan; 21(1):e1004339. PubMed ID: 38271295
[TBL] [Abstract][Full Text] [Related]
2. Use of Acitretin Among Girls and Women of Childbearing Age and Occurrence of Acitretin-Exposed Pregnancies in Germany.
Reinold J; Kollhorst B; Temme HL; Wentzell N; Haug U
Clin Drug Investig; 2023 Nov; 43(11):865-872. PubMed ID: 37906397
[TBL] [Abstract][Full Text] [Related]
3. Use of leflunomide among girls and women of childbearing age and occurrence of leflunomide-exposed pregnancies in Germany.
Princk C; Kollhorst B; Haug U
Reprod Toxicol; 2024 Apr; 125():108573. PubMed ID: 38460863
[TBL] [Abstract][Full Text] [Related]
4. Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis.
Wentzell N; Kollhorst B; Reinold J; Haug U
Clin Drug Investig; 2023 Feb; 43(2):109-117. PubMed ID: 36542272
[TBL] [Abstract][Full Text] [Related]
5. Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany.
Platzbecker K; Wentzell N; Kollhorst B; Haug U
Mult Scler Relat Disord; 2022 Nov; 67():104184. PubMed ID: 36174258
[TBL] [Abstract][Full Text] [Related]
6. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of isotretinoin exposure during pregnancy.
Dai WS; LaBraico JM; Stern RS
J Am Acad Dermatol; 1992 Apr; 26(4):599-606. PubMed ID: 1597546
[TBL] [Abstract][Full Text] [Related]
8. [Isotretinoin: compliance with recommendations in childbearing women].
Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
[TBL] [Abstract][Full Text] [Related]
9. Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida.
Haug U; Kollhorst B; Schink T; Thöne K; Dathe K; Schaefer C; Onken M
Pharmacoepidemiol Drug Saf; 2023 Feb; 32(2):148-157. PubMed ID: 36401747
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
11. Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France.
Autret-Leca E; Kreft-Jais C; Elefant E; Cissoko H; Darrouzain F; Grimaldi-Bensouda L; Attia S; Jonville-Béra AP
Drug Saf; 2010 Aug; 33(8):659-65. PubMed ID: 20635824
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.
Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Sturkenboom MC; Straus SM; Stricker BH
BMJ Open; 2014 Nov; 4(11):e005602. PubMed ID: 25392022
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.
Bérard A; Azoulay L; Koren G; Blais L; Perreault S; Oraichi D
Br J Clin Pharmacol; 2007 Feb; 63(2):196-205. PubMed ID: 17214828
[TBL] [Abstract][Full Text] [Related]
14. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
Autret E; Radal M; Jonville-Béra AP; Goehrs JM
Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
[TBL] [Abstract][Full Text] [Related]
15. Prescribing of endothelin receptor antagonists and riociguat in women of childbearing age in a large German claims database study.
Amann U; Nadine Wentzell ; Kollhorst B; Haug U
Reprod Toxicol; 2023 Aug; 119():108415. PubMed ID: 37245698
[TBL] [Abstract][Full Text] [Related]
16. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
Mitchell AA; Van Bennekom CM; Louik C
N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
[TBL] [Abstract][Full Text] [Related]
17. Safety of pregnancy after discontinuation of isotretinoin.
Dai WS; Hsu MA; Itri LM
Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pregnancies among women with epilepsy using valproate before or during pregnancy - A longitudinal claims data analysis from Germany.
Wentzell N; Haug U
Epilepsy Res; 2022 Jan; 179():106838. PubMed ID: 34891025
[TBL] [Abstract][Full Text] [Related]
19. Continued occurrence of Accutane-exposed pregnancies.
Honein MA; Paulozzi LJ; Erickson JD
Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
[TBL] [Abstract][Full Text] [Related]
20. [Isotretinoin in childbearing women: compliance with strengthen warnings].
Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
